facebook

Why Is My Risk of Retinal Detachment Increased After Posterior Capsule Rupture?

1 min read

Posterior capsule rupture (PCR) increases the risk of retinal detachment because it disrupts the natural barrier between the front and back compartments of the eye.

The posterior capsule normally separates the anterior segment (where cataract surgery occurs) from the vitreous cavity and retina. When it tears, vitreous gel can move forward. This traction can transmit force to the retina.

Retinal detachment occurs when the retina separates from the wall of the eye, often due to small retinal tears caused by vitreous traction.

Published UK National Ophthalmology Database (NOD) data show that PCR increases the relative risk of retinal detachment approximately 15–20 fold compared to uncomplicated surgery ¹. Importantly, the absolute risk remains low, but it is significantly higher than baseline ².

When PCR occurs, careful anterior vitrectomy is performed to remove prolapsed vitreous and minimise traction. Post-operatively, patients are monitored closely for:

  • Flashes of light
  • New floaters
  • A shadow or “curtain” in vision

Early detection allows prompt retinal repair ³.

At Blue Fin Vision®, patients with PCR are counselled specifically about retinal symptoms and provided urgent access pathways if needed.

Retinal detachment is uncommon, but vigilance is key.

References

  1. Day AC, Donachie PHJ, Sparrow JM, Johnston RL. The Royal College of Ophthalmologists’ National Ophthalmology Database Study of cataract surgery: report 1, visual outcomes and complications. Eye (Lond). 2015;29(4):552-560.
  2. Erie JC, Raecker ME, Baratz KH, Schleck CD, Robertson DM. Risk of retinal detachment after cataract extraction. Ophthalmology. 2006;113(11):2026-2032.
  3. Clark A, Morlet N, Ng JQ, Preen DB, Semmens JB. Risk for retinal detachment after phacoemulsification. Ophthalmology. 2012;119(5):916-921.

Related Topics

About Blue Fin Vision®

Blue Fin Vision® is a GMC-registered, consultant-led ophthalmology clinic with CQC-regulated facilities across London, Hertfordshire, and Essex. Patient outcomes are independently audited by the National Ophthalmology Database, confirming exceptionally low complication rates.